Skip to main content
Signal8

Hypha Labs, Inc. (FUNI)

Hypha Labs, Inc. focuses on the investigation, development, and market release of bioreactor systems across the United States. Their key offering is the Hypha Micropearl bioreactor, a specialized household device engineered to rapidly cultivate beneficial mushrooms for dietary intake. Founded in 2010, the company is officially based in Las Vegas, Nevada.

Sector: Services-Testing Laboratories

Industry: Medical - Diagnostics & Research

OTC:FUNI

As of the Aug 31, 2026 FINRA settlement, 5,937 FUNI shares were sold short (<0.01% of a 150.57M-share float, 1.00 days to cover).